Modulation of the endocannabinoid system by (S)-ketamine in an animal model of depression
Ketamine (KET) is recognized as rapid-acting antidepressant, but its mechanisms of action remain elusive. Considering the role of endocannabinoids (eCB) in stress and depression, we investigated if S-KET antidepressant effects involve the regulation of the eCB system using an established rat model o...
Saved in:
Main Authors: | Nicole R. Silva, Shokouh Arjmand, Luana B. Domingos, Adriano M. Chaves-Filho, Melina Mottin, Caroline C. Real, Anna L. Waszkiewicz, Pedro H. Gobira, Alessio Nicola Ferraro, Anne M. Landau, Carolina H. Andrade, Heidi K. Müller, Gregers Wegener, Sâmia R.L. Joca |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Pharmacological Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1043661824004900 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The endocannabinoid system’s genetic polymorphisms in sickle cell anemia patients
by: Amanda Cristina Meneguetti Berti, et al.
Published: (2024-12-01) -
Cannabinoids and the endocannabinoid system in liver diseases
by: Anna Parfieniuk-Kowerda, et al.
Published: (2024-12-01) -
Characterisation of the effects of the chemotherapeutic agent paclitaxel on neuropathic pain-related behaviour, anxiodepressive behaviour, cognition, and the endocannabinoid system in male and female rats
by: Chiara Di Marino, et al.
Published: (2025-01-01) -
Sleep-administered ketamine/psychedelics: A streamlined strategy to address two challenges in research on ketamine and psychedelics
by: Shokouh Arjmand, et al. -
The endocannabinoid system and ophthalmic pathologies: a review of molecular mechanisms and its implications for clinical practice
by: Tomasz Charytoniuk, et al.
Published: (2025-02-01)